Table 1 Cell proliferation assay

From: Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models

Cell line

EBV status

P53 status

Roniciclib

Cisplatin

   

Mean IC 50 (nM)

SD

Mean IC 50 (μM)

SD

HONE-1

Wild type

38.41

4.19

2.75

0.33

HK-1

Mutant (exon 5, codon 130, CTC>GTC

28.27

0.50

2.61

0.07

C666-1

+

Mutant (exon 7, codon 249 deletion)

10.97

2.63

9.00

0.94

CNE-2

Mutant (exon 8, codon 280, AGA>ACA)

31.02

3.09

  

HCT116 +/+

Wild type

23.73

3.23

  

HCT116 −/−

Wild type

25.48

0.98

  
  1. Cell lines were treated with roniciclib and cisplatin at various concentrations and the inhibitory concentrations were determined. Mean IC50 values were derived from three independent experiments; each concentration was done in triplicates. Respective mean IC50's and standard deviation (SD) were calculated
  2. IC 50 half-maximal inhibitory concentration, SD standard deviation